Showing results (51-60 of 181) with videos related to
Sort By:
Pageof 19
Tubercle|March 1, 1981
The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCGG A Rook, G M Bahr, J L StanfordImmunology|June 1, 1993
The interaction of Tamm-Horsfall protein with the extracellular matrixC Lambert, R Brealey, J Steele, et al.The Journal of Infectious Diseases|December 23, 1999
Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosisG T Seah, G M Scott, G A RookLancet (London, England)|May 27, 1995
Tuberculosis and cancer: parallels in host responses and therapeutic approaches?J M Grange, J L Stanford, G A RookPsychiatrische Praxis|January 1, 1989
[Family groups and family self-help groups for schizophrenic patients. Concepts, establishment, problems in implementation]H Schulze-Mönking, K Stricker, A Rook, et al.Advances in Experimental Medicine and Biology|February 9, 2021
Interleukin-31, a Potent Pruritus-Inducing Cytokine and Its Role in Inflammatory Disease and in the Tumor MicroenvironmentAlain H Rook, Kathryn A Rook, Daniel J LewisImmunology Today|July 1, 1994
Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balanceG A Rook, R Hernandez-Pando, S L LightmanImmunology|November 1, 1981
Inhibition of the proliferative response of peripheral blood lymphocytes to mycobacterial or fungal antigens by co-stimulation with antigens from various mycobacterial speciesG M Bahr, G A Rook, J L StanfordClinical and Experimental Immunology|October 1, 1976
Preliminary evidence for the trapping of antigen-specific lymphocytes in the lymphoid tissue of 'anergic' tuberculosis patientsG A Rook, J W Carswell, J L StanfordTubercle|March 1, 1981
How environmental mycobacteria may predetermine the protective efficacy of BCGJ L Stanford, M J Shield, G A RookPageof 19